Antibiotic Selection for Bacterial URTI in Breastfeeding Mothers

First-Line Antibiotic Options

The American Academy of Pediatrics and other medical societies recommend amoxicillin or amoxicillin-clavulanate as the first-line antibiotics of choice for breastfeeding mothers with bacterial upper respiratory tract infection, as penicillins and cephalosporins are the safest antibiotic classes during lactation 1
Amoxicillin is considered completely compatible with breastfeeding and is the reference treatment for bacterial URTIs 2
Amoxicillin-clavulanate is recommended as first-line for acute bacterial sinusitis and is compatible with breastfeeding 2, 3
Cephalosporins, such as cefuroxime-axetil and cefpodoxime-proxetil, are safe alternatives and compatible with breastfeeding 2

Macrolides, such as azithromycin and clarithromycin, are considered safe during breastfeeding, though there is a very low risk of hypertrophic pyloric stenosis if used during the first 13 days of the infant's life 2
Pristinamycin can be used for beta-lactam allergies 1

Tetracyclines, including doxycycline, should be avoided during breastfeeding due to risks to the fetus/infant 1
Trimethoprim-sulfamethoxazole should be avoided during breastfeeding 2
Fluoroquinolones should be avoided as first-line treatment and only used if absolutely necessary 1

Standard adult dosing of amoxicillin is 500-1000 mg every 8 hours 4
Standard adult formulations of amoxicillin-clavulanate should be used 3
Treatment duration for sinusitis is 7-10 days, and 5-day courses are effective for cefuroxime-axetil and cefpodoxime-proxetil 3

Infants should be monitored for uncharacteristic symptoms, particularly gastrointestinal disturbances, when their mothers are taking antibiotics 3

The European Respiratory Society recommends confirming bacterial URTI before starting antibiotic treatment, and using amoxicillin or amoxicillin-clavulanate as first-line treatment 2, 3
If a beta-lactam allergy is present, macrolides, such as azithromycin, should be used 2
The response to antibiotic treatment should be assessed at 48-72 hours, and reassessment rather than immediate antibiotic change should be considered if there is no improvement 3